131 related articles for article (PubMed ID: 37688641)
1. Letter to the editor: Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.
Shafique MA; Kumar A; Arsal SA
Neurosurg Rev; 2023 Sep; 46(1):237. PubMed ID: 37688641
[No Abstract] [Full Text] [Related]
2. Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma.
Saito T; Muragaki Y; Komori A; Nitta M; Tsuzuki S; Koriyama S; Ro B; Kawamata T
Neurosurg Rev; 2023 Aug; 46(1):202. PubMed ID: 37584729
[TBL] [Abstract][Full Text] [Related]
3. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
4. Serum IgE and Allergy Related Genotypes of IL-4R α and IL-13 Genes: Association with Glioma Susceptibility and Glioblastoma Prognosis.
Gohar MK; Ammar MG; Alnagar AA; Abd-ElAziz HA
Egypt J Immunol; 2018 Jan; 25(1):19-33. PubMed ID: 30242995
[TBL] [Abstract][Full Text] [Related]
5. Letter to the Editor Regarding: "Palliative Care Effects on Survival in Glioblastoma: Who Receives Palliative Care?".
Kamp MA; Golla H; Dinc N; Goldbrunner R; Senft C; Hellmich M; Voltz R
World Neurosurg; 2023 Oct; 178():270-272. PubMed ID: 37803664
[No Abstract] [Full Text] [Related]
6. [An immunohistochemical and ultrastructural study of 243 gliomas with reference to the prognosis].
Bian XW
Zhonghua Bing Li Xue Za Zhi; 1992 Jun; 21(3):171-3. PubMed ID: 1335846
[TBL] [Abstract][Full Text] [Related]
7. Short-term glioblastoma cultures may contain normal "glia-like" cells.
Sivakova I; MacLeod R; Mraz P; Kubikova E; Perzelova A
Bratisl Lek Listy; 2019; 120(9):625-629. PubMed ID: 31475543
[TBL] [Abstract][Full Text] [Related]
8. Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.
Zottel A; Novak M; Šamec N; Majc B; Colja S; Katrašnik M; Vittori M; Hrastar B; Rotter A; Porčnik A; Lah Turnšek T; Komel R; Breznik B; Jovčevska I
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765531
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Cheng S; Wang LY; Wang CH; Wang FK; Zhu B; Zhang P; Wang GH
Neuroreport; 2021 Apr; 32(6):507-517. PubMed ID: 33788813
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients.
Quesnel A; Coles N; Polvikoski TM; Karagiannis GS; Angione C; Islam M; Khundakar AA; Filippou PS
Sci Rep; 2022 Nov; 12(1):19868. PubMed ID: 36400876
[TBL] [Abstract][Full Text] [Related]
12. The Histone Demethylase NO66 Induces Glioma Cell Proliferation.
Wang Q; Liu PY; Liu T; Lan Q
Anticancer Res; 2019 Nov; 39(11):6007-6014. PubMed ID: 31704826
[TBL] [Abstract][Full Text] [Related]
13. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
14. Promising Prognosis Marker Candidates on the Status of Epithelial-Mesenchymal Transition and Glioma Stem Cells in Glioblastoma.
Takashima Y; Kawaguchi A; Yamanaka R
Cells; 2019 Oct; 8(11):. PubMed ID: 31653034
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
Weng W; Chen X; Gong S; Guo L; Zhang X
Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
[TBL] [Abstract][Full Text] [Related]
16. Nogo receptor-vimentin interaction: a novel mechanism for the invasive activity of glioblastoma multiforme.
Kang YH; Han SR; Jeon H; Lee S; Lee J; Yoo SM; Park JB; Park MJ; Kim JT; Lee HG; Lee MS; Lee SH
Exp Mol Med; 2019 Oct; 51(10):1-15. PubMed ID: 31649250
[TBL] [Abstract][Full Text] [Related]
17. CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.
Azambuja JH; Gelsleichter NE; Beckenkamp LR; Iser IC; Fernandes MC; Figueiró F; Battastini AMO; Scholl JN; de Oliveira FH; Spanevello RM; Sévigny J; Wink MR; Stefani MA; Teixeira HF; Braganhol E
Mol Neurobiol; 2019 May; 56(5):3260-3279. PubMed ID: 30117104
[TBL] [Abstract][Full Text] [Related]
18. Protein and mRNA levels of YKL-40 in high-grade glioma.
Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
[TBL] [Abstract][Full Text] [Related]
19. Epithelial Membrane Protein-3 and Chitinase-3-like Protein-1 as New Prognostic Predictors of Glioma, a Two-Gene Study.
Shen K; Zhu J; Zhou S; Jin X; Zhai W; Sun L; Wu J; Yu Z
Curr Oncol; 2023 Sep; 30(10):8686-8702. PubMed ID: 37887529
[TBL] [Abstract][Full Text] [Related]
20. Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients.
Tu Y; He S; Fu J; Li G; Xu R; Lu H; Deng J
Clin Transl Oncol; 2012 Mar; 14(3):214-20. PubMed ID: 22374425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
